'Grey's Anatomy' actor Eric Dane's diagnosis raises awareness for ALS
Summary by WXII
3 Articles
3 Articles
All
Left
Center
1
Right
XellSmart’s Allogeneic iPSC-Derived Cell Therapies for Parkinson’s Disease and ALS Officially Approved by the US FDA for Phase I Clinical Trials
The US FDA officially approved the Investigational New Drug application submitted by XellSmart Biopharmaceutical (Suzhou) Co., Ltd. for its universal allogeneic off-the-shelf iPS-derived dopaminergic neural progenitor cell therapy for the treatment of Parkinson’s disease. [XellSmart Biomedical (Suzhou) Co., Ltd] Press Release
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage